journal
Journals Pediatric Endocrinology Review...

Pediatric Endocrinology Reviews : PER

https://read.qxmd.com/read/32208562/insulin-adverse-events
#21
JOURNAL ARTICLE
Johnny Ludvigsson
The negative consequencies of diabetes treatment are traditionally regarded as caused by a disastrous treatment rather than adverse events of the insulin preparations. However, hypoglycemia, changes at the injection site (lipatrophy, lipoma), insulin allergy, obesity and increased risk of certain forms of cancer can easily be regarded as adverse events of the drug, and needle-phobia, psychological problems, increased risk of suicide are adverse events related to insulin and its administration. Also macroangiopathy and even microangiopathy to some extent can be regarded as adverse events as the most crucial part of the treatment of Type 1 diabetes is the insulin treatment...
March 2020: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/32208561/decision-support-systems-for-insulin-treatment-adjustment-in-people-with-type-1-diabetes
#22
JOURNAL ARTICLE
Revital Nimri
For people with type 1 diabetes, achieving optimal glycemic control requires use of intensive insulin therapy. To achieve this goal individuals are required to become proficient in accurately determining the appropriate amount of insulin needed to address a variety of situations throughout the day while considering numerous influencing factors. They also need to perform multiple tasks a day such as counting carbohydrates to accurately determine the required premeal bolus. There is also a need to periodically adjust insulin dosing as insulin sensitivity varies considerably over time...
March 2020: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/32208560/nearly-a-century-of-insulin-at-sanofi-looking-back-over-the-decades-of-production-and-development
#23
JOURNAL ARTICLE
Zsolt Bosnyak, Marcus Korn, Maximilian Bielohuby, Paulus Wohlfart, Norbert Tennagels
Almost a century ago, the first insulin was produced by Banting, Best, MacLeod and Collip in Toronto, thereby enabling life-saving treatment for people with diabetes. Since then, there have been many advancements in insulin production and development of new insulin analogues. In this article, we reflect on the rich heritage of Sanofi and its predecessor, Hoechst, in insulin production and development, from being one of the first companies to produce insulin in Europe in 1923, to modern-day insulin analogues and integrated care solutions at present-day Sanofi...
March 2020: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/32208559/eli-lilly-and-company-insulins-a-century-of-innovation
#24
JOURNAL ARTICLE
J K Malone, J H Jr Anderson, H A Wolpert, L L Ilag, B H Frank, M R De Felippis, C D Paavola, A L Orr, J M Beals
Eli Lilly and Company has played a pivotal role in the development of insulin products since its discovery in 1921. Through their dedication to pharmaceutical innovation, Josiah K. Lilly Sr. and George HA Clowes, in close collaborations with the University of Toronto, made insulin commercially available in 1923. Other innovations include the development and commercialization of the first biosynthetic human insulin, a rapid-acting insulin analog and analog mixtures. Lilly has advanced the field of knowledge with significant efforts toward developing a hepatic preferential basal insulin...
March 2020: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/32208558/the-discovery-and-structure-of-human-insulin
#25
JOURNAL ARTICLE
Chelsea Zimmerman, Gregory Forlenza, Desmond Schatz
The isolation and purification of insulin nearly 100 years ago has been one of the most ground-breaking discoveries in the history of medicine. Subsequent determination of the specific structure of human insulin has permitted further developments and modifications of the formulations of insulin to allow improved quality of care and quality of life for patients with diabetes. In this paper, we will review insulin structure and biosynthesis, treatment and prognosis of type 1 diabetes prior to insulin therapy, experimentation leading to the discovery of insulin, and the first patients to be treated with insulin...
March 2020: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31763804/primary-school-performance-of-girls-with-turner-syndrome-a-transcultural-assessment
#26
JOURNAL ARTICLE
Jan Lebl, Rasha Tarif Hamza, Judith Stoklasova, Jirina Zapletalova, Stanislava Kolouskova, Ondrej Soucek, Barbora Obermannova, Marta Snajderova, Shenali Anne Amaratunga, Zdenek Sumnik, Marketa Pavlikova, Stepanka Pruhova
OBJECTIVES: We analyzed primary school performance of girls with Turner syndrome (TS) in two distinct countries to ascertain if the cognitive phenotype of TS causes selective learning difficulties. METHODS: The cohort comprised of 44 Czech and 50 Egyptian girls with TS who attended public schools. School reports from grades 1 to 9 were obtained retrospectively from Czech participants with TS. Only recent school reports were obtained from Egyptian participants. Two controls per participant were requested - biological sisters and/or female classmates...
December 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31763803/endocrine-management-of-ovotesticular-dsd-an-index-case-and-review-of-the-literature
#27
REVIEW
Marissa J Kilberg, Michelle McLoughlin, Louisa C Pyle, Maria G Vogiatzi
Ovotesticular Differences in Sexual Development (OT-DSD) is a rare subset of DSD with great phenotypic variability characterized by the presence of both testicular and ovarian tissue in the same individual. Here, we describe the case of 46,XX, SRY-negative baby with ambiguous genitalia and ovotestis discovered during laparoscopy. As the family decided on female gender of rearing, the testicular component of the ovotestis was removed while the ovarian component was preserved. Stemming from this case, we review the clinical presentation of OT-DSD throughout ages, the role of genetics and risk for gonadal tumors when making decisions about prophylactic gonadectomy...
December 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31763802/pediatric-cushing-syndrome-an-overview
#28
JOURNAL ARTICLE
Christina Tatsi, Constantine A Stratakis
Endogenous Cushing syndrome (CS) is a rare entity in the pediatric population. Patients usually present with height deceleration and continuous weight gain, along with other classic stigmata of CS, such as acne, striae, hirsutism and others. The diagnosis of CS involves documentation of abnormal cortisol secretion with measurement of urinary free cortisol and midnight serum or salivary cortisol, and the use of the 1mg dexamethasone suppression test. After confirmation of CS, localization of the source of hypercortisolemia, involves differentiation of ACTH-dependent versus ACTH-independent causes of CS...
December 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31763801/osteoclasts-in-health-and-disease
#29
JOURNAL ARTICLE
Ulf H Lerner
Osteoclasts are multinucleated, giant cells originating from myeloid hematopoetic stem cells. These are the only cells in nature which can resorb bone. Differentiation of mononucleated osteoclast progenitor cells requires stimulation with M-CSF (macrophage colony-stimulating factor) for the cells to proliferate and survive and with RANKL (receptor activator of nuclear factor kappa B ligand) for differentiation along the osteoclastic lineage to cells which eventually fuse to the mature, multinucleated osteoclasts...
December 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31763800/for-debate-programing-of-the-autoimmune-diabetogenic-response-in-the-thymus-during-fetal-and-perinatal-life
#30
JOURNAL ARTICLE
Vincent Geenen, Didier Hober
No abstract text is available yet for this article.
December 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31599137/meeting-report-2019-annual-meeting-of-the-pediatric-endocrine-society-selected-highlights-baltimore-md-april-26-29-2019
#31
Danielle Guiffre, Grace Kim, Meenal B Gupta
No abstract text is available yet for this article.
September 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31599136/letter-to-the-editor-central-nervous-system-complications-in-diabetic-ketoacidosis
#32
EDITORIAL
Marta Baszyńska-Wilk, Marta Wysocka-Mincewicz, Małgorzata Wajda-Cuszlag, Anna Świercz, Mieczysław Szalecki
No abstract text is available yet for this article.
September 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31599135/growth-hormone-deficiency-and-excessive-sleepiness-a-case-report-and-review-of-the-literature
#33
REVIEW
Anisha Gohil, Erica Eugster
The somatotropic axis is intricately involved in normal sleep, as evidenced by the fact that hypothalamic growth hormone-releasing hormone (GHRH) has sleep promoting effects and pituitary growth hormone (GH) release is strongly associated with slow-wave sleep (SWS). Abnormalities in the somatotropic axis, such as GH deficiency of hypothalamic or pituitary origin, result in an alteration of normal sleep patterns which may explain the fatigue reported in these individuals. Sleep disorders such as narcolepsy, in which individuals abnormally enter rapid eye movement (REM) sleep at sleep onset are also associated with an altered GHRH circadian rhythm and abnormal GH secretion...
September 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31599134/are-we-aware-that-hyperphosphatemia-affects-mortality-and-morbidity-as-much-as-hypophosphatemia-in-pediatric-intensive-care-patients
#34
REVIEW
Yılmaz Akbaş, Alper Koker, Nilgün Erkek
OBJECTIVE: Hypophosphatemia was previously shown to affect the duration of admission, mechanical ventilator requirements, mortality and morbidity during pediatric intensive care. Different from previous studies, our study was planned with the aim of showing whether hyperphosphatemia affects morbidity and mortality in pediatric intensive care patients as much as hypophosphatemia. METHOD: Patients' ages, genders, reason for admission, underlying diseases, phosphorus levels examined on admission and on the 1-4th and 5-10th-days, duration on mechanical ventilation, duration of admission, final status and PRISM and PELOD scores calculated in the first 24 hours of admission were recorded...
September 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31599133/fgf23-and-associated-disorders-of-phosphate-wasting
#35
REVIEW
Anisha Gohil, Erik A Imel
Fibroblast growth factor 23 (FGF23), one of the endocrine fibroblast growth factors, is a principal regulator in the maintenance of serum phosphorus concentration. Binding to its cofactor αKlotho and a fibroblast growth factor receptor is essential for its activity. Its regulation and interaction with other factors in the bone-parathyroid-kidney axis is complex. FGF23 reduces serum phosphorus concentration through decreased reabsorption of phosphorus in the kidney and by decreasing 1,25 dihydroxyvitamin D (1,25(OH)2D) concentrations...
September 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31599132/emerging-mechanisms-of-gh-induced-lipolysis-and-insulin-resistance
#36
JOURNAL ARTICLE
Vishva M Sharma
Growth hormone (GH) is a pleiotropic hormone that coordinates an array of physiological processes including growth and metabolism. GH promotes anabolic action in all tissues except adipose, where it catabolizes stored fat to release energy for the promotion of growth in other tissues. However, chronic stimulation of lipolysis by GH results in an increased flux of free fatty acids (FFAs) into systemic circulation. Hence, a sustained release of high levels of GH contributes significantly to the development of insulin resistance by antagonizing the anti-lipolytic action of insulin...
September 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31245942/meeting-report-2019-annual-meeting-of-the-endocrine-society-new-orleans-la-march-23-26-2019-selected-highlights
#37
Swashti Agarwal, Amy Seagroves, Marwan Bakhach, Ishita Jindal
No abstract text is available yet for this article.
June 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31245941/height-sds-changes-%C3%AE-hsds-in-healthy-children-from-birth-to-18-years-with-correction-factors-for-measurement-intervals-of-less-than-one-year
#38
JOURNAL ARTICLE
Michael Hermanussen, Rebekka Mumm, Aileen Rintisch, Janina Tutkuviene, Andrej Suchomlinov, Kálmán Joubert, Angel Ferrandez Longas, Christiane Scheffler
BACKGROUND: Growth is volatile and non-linear. Assessing the instantaneous speed of growth (momentary height velocity) depends on the precision and the number of measurements and the duration of the observation period. Measurements at short intervals reflect both the non-linearity of growth and the technical error of measurements (TEM). MATERIAL: We reanalyzed longitudinal measurements of body length at age 0, 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months, from 1879 healthy infants (956 girls, 923 boys) from France (180 girls, 173 boys), Vilnius, Lithuania (507 girls, 507 boys), Lublin, Poland (67 girls, 56 boys), Zürich, Switzerland (94 girls, 102 boys) and Spain (108 girls, 95 boys); and longitudinal measurements of annual body height from age 2 to 18 years from 1528 healthy children and adolescents (774 girls, 754 boys) from France (41 girls, 47 boys), Vilnius, Lithuania (23 girls, 27 boys), Lublin, Poland (70 girls, 58 boys), Zürich, Switzerland (111 girls, 120 boys), Spain (94 girls, 74 boys), the Czech Republic (65 girls, 69 boys), Hungary (316 girls, 320 boys), and Berkeley, USA (54 girls, 39 boys)...
June 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31245940/hormones-and-their-structural-and-functional-effects-on-the-brain-how-can-we-change-our-practice-moving-forward
#39
JOURNAL ARTICLE
Bonnie McCann-Crosby, Laurel Hyle, David Mann, Sheila Gunn, Katherine Flynn, Jennifer Bercaw-Pratt, Oluyemisi Adeyemi, Jennifer Dietrich, Duong Tu, Paul F Austin, V Reid Sutton, Marni Axelrad, Lefkothea Karaviti
Is hormone treatment an invasive procedure? In this paper, we discuss aspects related to the choice of treating disorders of sex development (DSD) using hormones. Specifically, we focus on some of the challenging issues related to this treatment and the need to establish a standard of care for the use of hormone therapy in this patient population. The objectives of this paper are to: 1) Enhance understanding of the uncertainties in the decision-making process regarding hormonal interventions to treat patients with DSD...
June 2019: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/31245939/sleep-disorders-and-obesity-in-childhood-a-new-component-in-solving-obesity
#40
JOURNAL ARTICLE
Muge Atar, Özgür Pirgon, Atilla Buyukgebiz
Sleep disorders have been widely reported in obese individuals. Previous studies have shown that together with an increase in obesity prevalence, so does sleep duration in children and adolescents decrease. By contributing to energy imbalances, hormonal changes occurring with reduced sleep quality may cause weight gain and obesity. Current evidence shows that short sleep duration has effects on body weight and weight gain. Compared to individuals sleeping for a normal duration, insulin sensitivity is lower in those who sleep less...
June 2019: Pediatric Endocrinology Reviews: PER
journal
journal
40616
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.